Pharmacology
>> Metabolic Diseases
>>
Dyslipidemia Models
-
Pharmacology
- Cardiovascular
-
Central Nervous System
- Acetylcholine / Acetic Acid - Induced Writhing
- Anti-Metrazole Seizure Test - Mouse
- Catalepsy - Mouse
- Chronic Constriction Injury - Rat, Mouse
- Hot Plate - Mouse
- Hot Water - Tail Dip - Mouse
- Incisional Pain - Mouse, Rat
- Induced Vomiting - Ferret
- Irwin Screen Rat or Mouse
- Partial Sciatic Nerve Ligation - Rat, Mouse
- Rotarod - Mouse, Rat
- Sleep Time - Mouse, Rat
- Spinal Nerve Ligation - Rat, Mouse
- Spontaneous Motor Activity - Mouse
- Tail Flick - Mouse
-
Gastrointestinal
- Charcoal Meal Test - Rat
- Colonic Propulsion Velocity
- Dextran Sulfate Sodium Induced Colitis - Mouse
- Fecal Pellet Output - Mouse
- Gastric Emptying - Polystyrene Bead Test - Rat
- Glass Bead Test - Mouse
- Induced Vomiting - Ferret
- Prevention of Induced Diarrhea - Rat, Mouse
- Prevention of Induced Gastric Lesions and Intestinal Lesions
- Pylorus - Ileal Ligated Rat
- Pylorus Ligated Rat
- Inflammation
- Metabolic Diseases
- Pharmacokinetics
- Testing Services
- Industries
- About PSL
Dyslipidemia Models
The mutant models of metabolic syndrome have the advantage of high triglycerides, although it is best to cholesterol-feed them in order to make LDL cholesterol the predominant form (rats transport cholesterol primarily by HDL, unlike humans). In normal rats, placing them on a diet of 1.5% cholesterol and 0.5 % cholic acid will increase LDL cholesterol to levels seen in hypercholesterolemic humans. Hamsters transport cholesterol primarily via LDL cholesterol and are often used for this reason. Hamsters can also be cholesterol-fed in order to make them hypercholesterolemic. Primates are excellent models for cholesterol reduction studies as they metabolize cholesterol in the same manner as humans.